FEMY Femasys Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FEMY

Price (delayed)

$0.3553

Market cap

$21.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.27

Enterprise value

$20.8M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 25
Highlights
The EPS has surged by 70% year-on-year and by 43% since the previous quarter
FEMY's net income is up by 41% YoY and by 33% from the previous quarter
FEMY's quick ratio is down by 35% since the previous quarter
FEMY's gross margin is down by 7% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Peers: OFIX

Key stats

What are the main financial stats of FEMY

FEMY stock price

How has the Femasys stock price performed over time
Intraday
-3.48%
1 week
-6.4%
1 month
-4.46%
1 year
-55.59%
YTD
-38.34%
QTD
-15.45%

Financial performance

How have Femasys's revenue and profit performed over time
Revenue
$2.38M
Gross profit
$1.46M
Operating income
-$16.35M
Net income
-$12.4M
Gross margin
61.6%
Net margin
-521.8%
Femasys's net margin has soared by 58% YoY and by 36% from the previous quarter
The company's operating margin rose by 41% YoY and by 10% QoQ
FEMY's net income is up by 41% YoY and by 33% from the previous quarter
Femasys's revenue has increased by 40% YoY and by 3.6% QoQ

Price vs fundamentals

How does FEMY's price correlate with its fundamentals

Growth

What is Femasys's growth rate over time

Valuation

What is Femasys stock price valuation
P/E
N/A
P/B
2.94
P/S
9.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.75
The EPS has surged by 70% year-on-year and by 43% since the previous quarter
FEMY's price to book (P/B) is 58% less than its last 4 quarters average of 7.3 and 27% less than its 5-year quarterly average of 4.2
The equity has increased by 24% since the previous quarter
The price to sales (P/S) is 48% less than the 5-year quarterly average of 19.9 and 5% less than the last 4 quarters average of 10.9
Femasys's revenue has increased by 40% YoY and by 3.6% QoQ

Efficiency

How efficient is Femasys business performance
The return on sales has surged by 60% year-on-year and by 38% since the previous quarter
The ROE has soared by 52% from the previous quarter and by 34% YoY
Femasys's return on invested capital has increased by 49% YoY and by 44% QoQ
The return on assets has increased by 46% year-on-year and by 37% since the previous quarter

Dividends

What is FEMY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FEMY.

Financial health

How did Femasys financials performed over time
The total assets is 79% greater than the total liabilities
The company's total liabilities fell by 38% QoQ and by 18% YoY
FEMY's quick ratio is down by 35% since the previous quarter
Femasys's debt is 35% less than its equity
FEMY's debt to equity has dropped by 83% year-on-year and by 19% since the previous quarter
Femasys's debt has decreased by 38% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.